Results 211 to 220 of about 49,135 (301)

Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin

Thrombosis and Haemostasis, 2016
G. Lip, A. Keshishian, S. Kamble, Xianying Pan, J. Mardekian, R. Horblyuk, M. Hamilton   +6 more
semanticscholar   +1 more source

Trends and Hot Spots in Research Related to Rivaroxaban: Bibliometric Analysis. [PDF]

Clin Pract
Pawlak K, Kruszyna Ł, Wesołowska A, Karaźniewicz-Łada M.   +3 more
europepmc   +1 more source

Cost-effectiveness of dabigatran for thromboembolic events prevention in atrial fibrillation patients in Chile. [PDF]

Cost Eff Resour Alloc
Abbot T, Armijo N, Orellana LR, Jiménez AG, Balmaceda C, Espinoza M.   +5 more
europepmc   +1 more source

A dabigatran iv. antidótumának, az idarucizumabnak első hazai alkalmazásai sürgős műtétek esetén = The first uses of iv. idarucizumab for dabigatran reversal in cases of urgent surgeries in Hungary [PDF]

, 2017
Barabás, Éva, Bencsik, Gábor, Bodócs, Ildikó, Borbola, József, Driesz, Lajos, Hajdú, Attila, Herr, György, Pál, László, Szántó, Zoltán   +8 more
core   +1 more source

Why dabigatran is worth to be chosen? The cardiologist’s point of view based on the recent data available

, 2018
Dariusz A. Kosior
openalex   +1 more source

Dabigatran (October 2011)

Cleveland Clinic Journal of Medicine, 2011
openaire   +2 more sources

Safety and effectiveness of Rivaroxaban, Dabigatran and Apixaban in patients with non-valvular atrial fibrillation for stroke prophylaxis. [PDF]

BMC Neurol
Tanoğlu C, Ersoy A.
europepmc   +1 more source

PCV15 COST-EFFECTIVENESS ANALYSIS OF DABIGATRAN ETEXILATE VERSUS ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE REPLACEMENT UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE

, 2009
RA Fernandes, FF Quintella, V Teich
openalex   +1 more source

Fibrinography and thrombography (thrombodynamics-4D) in atrial fibrillation assessment of direct oral anticoagulants in geriatrics patients aged 80 years and older receiving direct oral anticoagulant therapy. [PDF]

Res Pract Thromb Haemost
Foulon-Pinto G, Jourdi G, Delrue M, Lafuente-Lafuente C, Cavalie C, Gouin-Thibault I, Le Guen J, Gaussem P, Mirault T, Puymirat E, Lecompte T, Pautas E, Curis E, Siguret V.   +13 more
europepmc   +1 more source

Prevalence and Outcomes Associated with Idarucizumab Administration in Trauma Patients on Preinjury Dabigatran Therapy: Analyzing Clinical Utilization in 942 Patients from 74 Hospitals [PDF]

Rebecca Moore, Ransom J. Wyse, J. Bruce Jacobs, Samir M. Fakhry, Nina Y. Wilson, Jeneva M. Garland   +5 more
openalex   +1 more source